Federal Court Strikes Down Blue Cross Of Michigan's Denial Of Applied Behavior Analysis Therapy To Children With Autism
According to the suit, ABA therapy is a medically and scientifically accepted treatment that enables children with autism to increase communication, motor, and reasoning skills; enhance social functioning; decrease negative behaviors; and lead more independent lives. The U.S. Surgeon General, the National Institutes of Health, the American Academy of Pediatrics, the Medicare and Medicaid systems, and leading scholars and researchers have all found ABA therapy to be effective in treating autism spectrum disorder.
The evidence also shows that denying or delaying treatment can have profound negative consequences to the children. Denial of therapy forever destroys the potential of these children to live full and independent lives.
Despite this evidence, Blue Cross has for years characterized ABA therapy as "experimental" and refused coverage to all children with autism. It was this characterization and denial of coverage for ABA therapy that the federal court in Detroit struck down as illegal.
This ruling comes on the heels of another victory by the same law firms who litigated Berge, et al. v. United States of America, et al., Case No. 10-00373 (D.D.C., Hon. Reggie B. Walton), in which over 20,000 military families successfully sued the Department of Defense and Tricare for their denial of coverage for ABA therapy on similar grounds.The attorneys for the Plaintiff families in Potter v. Blue Cross are: Gerard V. Mantese, Esq. Brian M. Saxe, Esq.Mantese Honigman Rossman and Williamson, P.C.1361 E. Big Beaver Road Troy, Michigan 48083248-457-9200 Office248-515-6419 Cell email@example.com firstname.lastname@example.org John J. Conway, Esq. John J. Conway P.C.26622 Woodward Ave., Suite 225 Royal Oak, Michigan 48067313-961-6525 Office313-574-2148 Cell email@example.com SOURCE Mantese Honigman Rossman and Williamson, P.C.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts